Seizure Outcomes Following the Use of Generic versus Brand-Name Antiepileptic Drugs A Systematic Review and Meta-Analysis

被引:143
|
作者
Kesselheim, Aaron S. [1 ,2 ]
Stedman, Margaret R. [1 ,2 ]
Bubrick, Ellen J. [2 ,3 ]
Gagne, Joshua J. [1 ,2 ]
Misono, Alexander S. [1 ,2 ]
Lee, Joy L. [1 ,2 ]
Brookhart, M. Alan [4 ]
Avorn, Jerry [1 ,2 ]
Shrank, William H. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Brigham & Womens Hosp, Dept Neurol, Div Epilepsy, Boston, MA 02115 USA
[4] UNC Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA
基金
美国医疗保健研究与质量局;
关键词
SUBSTITUTION; BIOAVAILABILITY; CARBAMAZEPINE; EPILEPSY; DISSOLUTION; IDENTIFICATION; LAMOTRIGINE; MEDICATION; PATIENT; EVENTS;
D O I
10.2165/10898530-000000000-00000
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The automatic substitution of bioequivalent generics for brand-name antiepileptic drugs (AEDs) has been linked by anecdotal reports to loss of seizure control. Objective: To evaluate studies comparing brand-name and generic AEDs, and determine whether evidence exists of superiority of the brand-name version in maintaining seizure control. Data Sources: English-language human studies identified in searches of MEDLINE, EM BASE and International Pharmaceutical Abstracts (1984 to 2009). Study Selection: Randomized controlled trials (RCTs) and observational studies comparing seizure events or seizure-related outcomes between one brand-name AED and at least one alternative version produced by a distinct manufacturer. Data Extraction: We identified 16 articles (9 RCTs, 1 prospective non-randomized trial, 6 observational studies). We assessed characteristics of the studies and, for RCTs, extracted counts for patients whose seizures were characterized as 'controlled' and 'uncontrolled'. Data Synthesis: Seven RCTs were included in the meta-analysis. The aggregate odds ratio (n = 204) was 1.1(95% CI 0.9, 1.2), indicating no difference in the odds of uncontrolled seizure for patients on generic medications compared with patients on brand-name medications. In contrast, the observational studies identified trends in drug or health services utilization that the authors attributed to changes in seizure control. Conclusions: Although most RCTs were short-term evaluations, the available evidence does not suggest an association between loss of seizure control and generic substitution of at least three types of AEDs. The observational study data may be explained by factors such as undue concern from patients or physicians about the effectiveness of generic AEDs after a recent switch. In the absence of better data, physicians may want to consider more intensive monitoring of high-risk patients taking AEDs when any switch occurs.
引用
收藏
页码:605 / 621
页数:17
相关论文
共 50 条
  • [41] Seizure control and adverse outcomes of lamotrigine use during pregnancy: A systematic review and meta-analysis
    Wan, Xin
    Wu, Yunhong
    Zou, Qing
    Yuan, Bin
    Huang, Liping
    Hu, Maorong
    EPILEPSY & BEHAVIOR, 2024, 157
  • [42] Perinatal outcomes following stimulated versus unstimulated IVF: a systematic review and meta-analysis
    Kamath, M.
    Mascarenhas, M.
    Sunkara, S. K.
    HUMAN REPRODUCTION, 2017, 32 : 302 - 303
  • [43] Commentary: Consensus Guidelines on the Appropriate Use of Brand-Name and Generic Anti-Seizure Medication for the Management of Epilepsy in the Gulf Region
    Alsaadi, Taoufik
    Almadani, Abubaker
    Al-Hashel, Jasem
    Al Salti, Abdullah
    Melikyan, Gayane
    Khan, Riaz Ahmed
    NEUROLOGY AND THERAPY, 2023, 12 (04) : 1015 - 1031
  • [44] Commentary: Consensus Guidelines on the Appropriate Use of Brand-Name and Generic Anti-Seizure Medication for the Management of Epilepsy in the Gulf Region
    Taoufik Alsaadi
    Abubaker Almadani
    Jasem Al-Hashel
    Abdullah Al Salti
    Gayane Melikyan
    Riaz Ahmed Khan
    Neurology and Therapy, 2023, 12 : 1015 - 1031
  • [45] Levetiracetam Versus Phenytoin for Seizure Prophylaxis Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis
    Yang, Yong
    Zheng, Fangshuo
    Xu, Xin
    Wang, Xuefeng
    CNS DRUGS, 2016, 30 (08) : 677 - 688
  • [46] Levetiracetam Versus Phenytoin for Seizure Prophylaxis Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis
    Yong Yang
    Fangshuo Zheng
    Xin Xu
    Xuefeng Wang
    CNS Drugs, 2016, 30 : 677 - 688
  • [47] North American cost analysis of brand name versus generic drugs for the treatment of glaucoma
    Malvankar-Mehta, Monali S.
    Feng, Lucy
    Hutnik, Cindy M. L.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2019, 11 : 789 - 798
  • [48] Comparative safety of generic versus brand calcineurin inhibitors in solid organ transplant patients: A systematic review and meta-analysis
    Tanni, Kaniz Afroz
    Qian, Jingjing
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, 63 (03) : 709 - 719
  • [49] COMPARATIVE SAFETY OF GENERIC VERSUS BRAND CALCINEURIN INHIBITORS IN SOLID ORGAN TRANSPLANT PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Tanni, K. A.
    Qian, J.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2023, 19 (03): : 568 - 568
  • [50] Opioids combined with antidepressants or antiepileptic drugs for cancer pain: Systematic review and meta-analysis
    Kane, Chris M.
    Mulvey, Matthew R.
    Wright, Sophie
    Craigs, Cheryl
    Wright, Judy M.
    Bennett, Michael I.
    PALLIATIVE MEDICINE, 2018, 32 (01) : 276 - 286